Fakeeh Care Group, a healthcare service provider in Saudi Arabia, and Fosun Pharma, an innovation-driven global healthcare company, have forged a strategic partnership to advance cell and gene therapy and tele-diagnostics in Saudi Arabia.
The first phase of ‘Saudization’ in Saudi Arabia’s healthcare sector is now underway, effective from 17 April. Saudization is a government policy to increase the number of Saudi nationals employed and reduce the reliance on expats in the workforce.
There’s a palpable sense of purpose within the HBI team, who I can report are relishing the prospect of hosting the industry we serve in Paris for the very first time later this month. If you’re reading this and haven’t yet got your ticket, it’s not too late to book now. Please join us for […]
Saudi Arabian healthcare group SMC Hospitals is planning an initial public offering in Riyadh, as part of a trend of healthcare firms going public in the kingdom.
Demand for GLP-1 receptor agonists (the class of drugs used to treat obesity and diabetes) has been growing rapidly, opening up more and more opportunities in the market, such as ‘holistic’ online prescription services. We’ve seen both the positives and negatives of the use of GLP-1 RAs in the US and Europe, from transforming people’s health for the better to misuse and inappropriate supply. But what do we know about the market in the Middle East?
This week’s infographic looks at the performance of KSA’s top 5 for-profit hospitals since 2019. The hospital providers have been ranked based on their revenues (in €million). The data comes from HBI Intelligence.
Almoosa Health, a leading Saudi-based healthcare provider, has received approval for an initial public offering (IPO) from the Saudi Capital Market Authority (CMA), the country’s financial board.
Listed Saudi hospital group Dallah Health has signed a binding share purchase and subscription agreement with minority shareholder Ayyan Investment to acquire its shares for approximately SAR 660 million riyals (~$176 million).
The afternoon of day two of HBI 2024 included sessions on dental services, veterinary services the move to preventive healthcare, decarbonisation and the race to decarbonise.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.